ZENTEC - Fundamental Analysis: Financial Health & Valuation
Back to ListFundamental Rating: 4.2
| Stock Code | ZENTEC | Market Cap | 15,088 Cr. | Current Price | 1,671 ₹ | High / Low | 2,268 ₹ |
| Stock P/E | 69.8 | Book Value | 195 ₹ | Dividend Yield | 0.12 % | ROCE | 32.9 % |
| ROE | 24.6 % | Face Value | 1.00 ₹ | DMA 50 | 1,498 ₹ | DMA 200 | 1,468 ₹ |
| Chg in FII Hold | 0.45 % | Chg in DII Hold | 2.20 % | PAT Qtr | 47.8 Cr. | PAT Prev Qtr | 46.2 Cr. |
| RSI | 62.4 | MACD | 79.5 | Volume | 5,53,118 | Avg Vol 1Wk | 5,81,298 |
| Low price | 1,223 ₹ | High price | 2,268 ₹ | PEG Ratio | 0.18 | Debt to equity | 0.00 |
| 52w Index | 42.9 % | Qtr Profit Var | 23.8 % | EPS | 23.9 ₹ | Industry PE | 66.6 |
📊 Financials: ZENTEC demonstrates strong efficiency with ROCE at 32.9% and ROE at 24.6%, reflecting excellent capital utilization. Debt-to-equity ratio is 0.00, making it debt-free and financially stable. EPS of ₹23.9 supports profitability, while quarterly PAT improved (₹46.2 Cr → ₹47.8 Cr, +23.8%), showing consistent earnings growth.
💹 Valuation: Current P/E of 69.8 is slightly above industry average (66.6), suggesting premium valuation. PEG ratio of 0.18 highlights attractive growth potential at reasonable valuations. P/B ratio (~8.6) is elevated relative to book value, but justified by strong return metrics. Dividend yield of 0.12% is negligible, with focus on reinvestment.
🏢 Business Model & Advantage: ZENTEC operates in technology and engineering solutions, benefiting from strong demand cycles, innovation, and scale. Competitive advantage lies in debt-free status, superior efficiency metrics, and institutional support (FII +0.45%, DII +2.20%).
📈 Entry Zone: Attractive accumulation near ₹1,550–₹1,600 (close to DMA 200 support). Current price (₹1,671) is near fair entry, with resistance at ₹2,200–₹2,250.
⏳ Long-Term Holding: Strong candidate for 3–5 year horizon given superior fundamentals, growth potential, and debt-free balance sheet. Partial profit booking advised near ₹2,200–₹2,250 resistance zones.
Positive
- High ROCE (32.9%) and ROE (24.6%)
- Debt-free balance sheet (0.00 debt-to-equity)
- EPS of ₹23.9 supports profitability
- Quarterly PAT growth (+23.8%)
- Institutional support (FII +0.45%, DII +2.20%)
Limitation
- High P/E (69.8 vs industry 66.6)
- Dividend yield of only 0.12%
- P/B ratio (~8.6) is elevated
Company Negative News
- Premium valuation raises risk of correction
Company Positive News
- Strong quarterly PAT growth
- Institutional inflows (FII and DII) reflect confidence
- Debt-free status enhances financial strength
Industry
- Industry P/E at 66.6 reflects premium sector valuations
- ZENTEC trades slightly above peers but with stronger efficiency metrics
Conclusion
ZENTEC is fundamentally strong with excellent efficiency, debt-free balance sheet, and consistent profit growth. Valuations are premium but supported by growth. Entry is ideal near ₹1,550–₹1,600, with profit booking advised near ₹2,200–₹2,250. Long-term investors can hold for 3–5 years to benefit from sector resilience and superior fundamentals.